Patent · US Active

Aminopyrazine compounds

US8962623B2 · kind B2 · utility

4Cited by

0References

13Claims

0Family size

Assignee

Locus Pharmaceuticals, Inc. · US

Inventors

Rupa Shetty · King of Prussia, US
Kevin J. Moriarity · Norristown, US
Martha J. Kelly · Norristown, US
Bin Liu · Fishers, US
Jinming Zou · Monroe, US
Kristofer Moffett · Blue Bell, US
Younghee Lee · Blue Bell, US

Key dates

Filing date	Feb 29, 2012
Grant date	Feb 24, 2015
Priority date	—
Expiry date	Feb 29, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D491/056
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I):wherein all symbols have the same meanings as defined in the specification; a salt thereof, a solvate thereof, an N-oxide thereof, or a prodrug thereof, has an Itk inhibitory activity, and is useful as a method for preventing and/or treating atopic dermatitis, and the like.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.